Invention Grant
- Patent Title: Quinoline potassium channel inhibitors
-
Application No.: US10572167Application Date: 2004-09-17
-
Publication No.: US07825131B2Publication Date: 2010-11-02
- Inventor: Christopher J. Dinsmore , Jeffrey M. Bergman
- Applicant: Christopher J. Dinsmore , Jeffrey M. Bergman
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Heidi M. Struse; Richard S. Parr; Mark R. Daniel
- International Application: PCT/US2004/030433 WO 20040917
- International Announcement: WO2005/030792 WO 20050407
- Main IPC: C07D401/02
- IPC: C07D401/02 ; A61K31/47
Abstract:
The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
Public/Granted literature
- US20070078154A1 Quinoline potassium channel inhibitors Public/Granted day:2007-04-05
Information query
